Eltrombopag with gemcitabine-based chemotherapy in patients with advanced solid tumors: a randomized phase I study - Wikidata - wikimedia - TriplyDB

Eltrombopag with gemcitabine-based chemotherapy in patients with advanced solid tumors: a randomized phase I study

Eltrombopag with gemcitabine-based chemotherapy in patients with advanced solid tumors: a randomized phase I study

http://www.wikidata.org/entity/Q33417372

about

Thrombopoietin receptor agonists for prevention and treatment of chemotherapy-induced thrombocytopenia in patients with solid tumours Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation.Beyond immune thrombocytopenia: the evolving role of thrombopoietin receptor agonists.Romiplostim for therapy-related thrombocytopenia in pediatric malignancies.From chronic immune thrombocytopenia to severe aplastic anemia: recent insights into the evolution of eltrombopag.Thrombopoietin receptor agonists for prevention and treatment of chemotherapy-induced thrombocytopenia in patients with solid tumours.Eltrombopag for thrombocytopenia in patients with advanced solid tumors receiving gemcitabine-based chemotherapy: a randomized, placebo-controlled phase 2 study.Drug-Induced Hematological Cytopenia in Kidney Transplantation and the Challenges It Poses for Kidney Transplant Physicians

P2860

Q24186714-498EB24B-344F-4667-9517-7C5FC03F63F9 Q30248355-7DAE9300-F796-4DE0-BF76-B24A637EE7BE Q30399669-4450B6F3-289F-4235-A2F7-3294019BC8E8 Q33438904-A9633B8A-31F3-4273-BA47-7C34E5287662 Q33441627-1A5B38B8-9CAA-44B6-8554-E8C9B14E1472 Q47409875-B995C193-CB50-48FB-9AF0-9257BFD1E791 Q50231149-247A4721-73D4-4F35-85BB-3531D6CAFBD7 Q58805821-6D99E975-E88C-429A-AAC8-89A092FF6DFC

P2860

Eltrombopag with gemcitabine-based chemotherapy in patients with advanced solid tumors: a randomized phase I study

http://www.wikidata.org/entity/Q33417372

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Eltrombopag with gemcitabine-b ...... rs: a randomized phase I study

@ast

Eltrombopag with gemcitabine-b ...... rs: a randomized phase I study

@en

type

label

Eltrombopag with gemcitabine-b ...... rs: a randomized phase I study

@ast

Eltrombopag with gemcitabine-b ...... rs: a randomized phase I study

@en

prefLabel

Eltrombopag with gemcitabine-b ...... rs: a randomized phase I study

@ast

Eltrombopag with gemcitabine-b ...... rs: a randomized phase I study

@en

P1433

Q33417372-C934C2F3-957B-4ED0-9212-A1C566CCD8F2

P1476

Q33417372-383BF21A-631E-428E-BD8C-9A8449C81FC6

P2093

Q33417372-0DA06759-B2D6-4807-A0DA-2FD4A901125D

Q33417372-1F2F5A2F-6971-414F-BBE9-972B890B23CB

Q33417372-36085F43-1287-48A2-9D63-00071D35C1D1

Q33417372-57778750-AA38-4A4B-8985-5735D1166081

Q33417372-6126C222-2312-48A6-9950-AD300A8CEFF4

Q33417372-77F81306-77B8-44CC-9A34-A0875AB0B9C0

Q33417372-A83AC560-57EC-4A4D-BFEE-4D38930C7CD1

Q33417372-BB31EF7A-9195-4C94-9522-7AC774ED9354

Q33417372-E029959F-C02E-4483-932D-D78D7720CB77

Q33417372-EB19EE61-6611-40C1-9862-DB41CBA2B8FF

P2860

Q33417372-022D5237-FD87-4412-8CA0-C54206725A7E

Q33417372-19BCE812-3228-4EA1-90EE-29CE1A54D6BA

Q33417372-22C008EE-15FF-4BBB-AB34-9A6BC9E9D0AB

Q33417372-407F9E38-7C3F-40E0-8F24-4FC0DE9C602E

Q33417372-499A9188-8A13-4103-A6D2-B8CEF94DA97C

Q33417372-54945CF2-7DAD-4C5D-BF4A-C88F6729A125

Q33417372-57BA2A6D-ECDC-4B04-A43C-E538EC951CAB

Q33417372-588C8932-115C-4450-9172-09E2E3CDC3F5

Q33417372-5CC927A3-DC89-4028-B3B1-637626C1C50C

Q33417372-7AB88770-D65D-417F-B21E-D9FD9D30E4AC

P304

Q33417372-08300A8E-2B2A-4479-9706-BBFE99743ED5

P31

Q33417372-EFE6147F-7204-4CF7-AD43-4678908A6CCE

P356

Q33417372-95916EEF-8B25-483A-A2A7-6B3129CFAA35

P407

Q33417372-D484EE13-708F-42E9-AD25-0A44A89CE2BF

P433

Q33417372-7BAE4284-EEF9-481E-8020-0A562F5CEB34

P478

Q33417372-DDA6DF01-5234-4755-A79F-AE2CE8614DF8

P50

Q33417372-7365F099-9A06-479B-83B3-92B9F7FF32C6

P577

Q33417372-0F108180-3ECA-4D95-A20D-D4746BF95FD9

P5875

Q33417372-D79C36F9-8369-4EFF-B62E-B5BCB2F80A3E

P698

Q33417372-2B92B12A-1A8A-4559-AF29-5B52873C34BB

P921

Q33417372-9F02837C-BB2F-45F4-88F6-5C52F8A758F2

P932

Q33417372-65E9B677-3165-4280-9CBA-BEB5D25D6E54

P356

P1433

Cancer Medicine

P1476

Eltrombopag with gemcitabine-b ...... rs: a randomized phase I study

@en

P2093

Bhabita Mayer

http://www.w3.org/2001/XMLSchema#string

Boguslawa Karaszewska

http://www.w3.org/2001/XMLSchema#string

Brendan M Johnson

http://www.w3.org/2001/XMLSchema#string

Conrad A Messam

http://www.w3.org/2001/XMLSchema#string

Donald A Richards

http://www.w3.org/2001/XMLSchema#string

Eric S Winer

http://www.w3.org/2001/XMLSchema#string

Frederic Forget

http://www.w3.org/2001/XMLSchema#string

Howard Safran

http://www.w3.org/2001/XMLSchema#string

Kirushna Kumar

http://www.w3.org/2001/XMLSchema#string

Lee Hartner

http://www.w3.org/2001/XMLSchema#string

P2860

Dose reductions and delays: limitations of myelosuppressive chemotherapy.

Importance of predosing of recombinant human thrombopoietin to reduce chemotherapy-induced early thrombocytopenia.

Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trial.

Phase III trial of gemcitabine plus carboplatin versus single-agent gemcitabine in the treatment of locally advanced or metastatic non-small-cell lung cancer: the Swedish Lung Cancer Study Group.

First-line gemcitabine and carboplatin in advanced ovarian carcinoma: a phase II study.

Maintaining the dose intensity of ICE chemotherapy with a thrombopoietic agent, PEG-rHuMGDF, may confer a survival advantage in relapsed and refractory aggressive non-Hodgkin lymphoma.

Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: a trial of the Eastern Cooperative Oncology Group.

Comparative analyses of the small molecule thrombopoietin receptor agonist eltrombopag and thrombopoietin on in vitro platelet function.

Gemcitabine versus gemcitabine combined with cisplatin treatment locally advanced or metastatic pancreatic cancer: a retrospective analysis.

Anemia and thrombocytopenia in patients undergoing chemotherapy for solid tumors: a descriptive study of a large outpatient oncology practice database, 2000-2007.

P304

16-26

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CAM4.326

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-08-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265130790

http://www.w3.org/2001/XMLSchema#string

P698

25165041

http://www.w3.org/2001/XMLSchema#string

P921

P932

4312114

http://www.w3.org/2001/XMLSchema#string